Melatonin is often discussed as if it were a small, simple answer to a large problem: trouble sleeping.
It is available without a prescription in the United States. It comes in gummies, quick-dissolve tablets, extended-release capsules, and combinations with other ingredients. The label usually offers one obvious number: milligrams.
That number can make melatonin look more straightforward than it is.
Melatonin is part of the body’s timing system. That is why it belongs in a brain-health conversation. Sleep timing, alertness, and daytime functioning all involve the brain. But a biological role is not the same thing as proof that supplemental melatonin improves brain health, memory, mood, or cognition.
The more useful question is not simply, “Does melatonin work?” It is: for what outcome, in whom, in what formulation, at what time, and with what confidence?
Timing is part of the intervention
Melatonin is not best understood as a generic sedative. Its central role is signaling biological night. That makes timing relevant in a way that is easy to overlook when a product is marketed simply for “sleep support.”
A 2024 systematic review and dose-response meta-analysis found that both timing and dose varied substantially across randomized trials. That is not a minor research detail. If studies use different formulations, doses, schedules, populations, and definitions of better sleep, a single conclusion about “melatonin” becomes less satisfying.
Recent evidence reviews point in a generally favorable direction for some sleep outcomes compared with placebo. A 2025 scoping review of systematic reviews found that most meta-analyses favored melatonin over an inactive comparator. But it also found major variation in what researchers meant by sleep quality and how they measured it. Only a small fraction of the included reviews met all of the authors’ predefined markers of methodological rigor.
That does not mean melatonin does nothing. It means the evidence is not a blank check for every sleep complaint, every dose, or every product on a shelf.
Sleep measures are not brain-health outcomes
It is reasonable to care about sleep in a brain-health context. Poor or disrupted sleep can affect attention, reaction time, learning, and how a day feels.
Still, it is easy to take a shortcut in the reasoning: melatonin may help a sleep measure, sleep matters for the brain, therefore melatonin is a brain supplement.
That conclusion asks more of the evidence than it can provide.
Research might measure time to fall asleep, total sleep time, a sleep diary, or a questionnaire. Those are meaningful outcomes, but they are not interchangeable. They also do not establish that a supplement prevents cognitive decline, improves memory in healthy adults, or treats a neurological or psychiatric condition.
Sometimes the brain-health value of a supplement is best framed as a question about sleep and timing, not as a promise about the brain itself.
A label is not a laboratory result
There is another issue that deserves more attention: whether the number on a melatonin label reliably describes what is in the product.
In a 2025 analysis conducted by FDA-affiliated researchers, 110 melatonin supplements marketed for children were tested using a validated laboratory method. Measured melatonin content ranged from 0% to 667% of the label declaration.
That finding does not prove that every melatonin product is inaccurately labeled. It also does not tell us the quality of any particular adult product. But it does challenge the casual assumption that “5 mg” on a bottle necessarily means a consistent, known exposure.
This matters because dose-response questions are already unsettled. It also matters because gummies and other flavored products can look less like pharmacologically active products and more like candy. “Over the counter” tells us something about how a product is sold. It does not tell us that its contents are uniform, that its use is risk-free, or that more is better.
What the evidence supports, and what it does not
Short-term melatonin use appears to be tolerated by many adults in research studies. Reported side effects can include headache, dizziness, nausea, and sleepiness. Long-term safety data remain limited, particularly at doses above those the body naturally produces.
Evidence is stronger for some circadian-timing questions than for the broad idea of chronic insomnia as one uniform problem. Professional guidance has long noted that evidence is not strong enough to recommend melatonin as a general answer for chronic insomnia in adults.
That distinction is important. Difficulty sleeping can arise from many different patterns, contributors, medications, medical conditions, schedules, and environments. A product that may shift timing is not automatically an answer to all of them.
And when a supplement seems to help, that observation is still only one piece of information. It does not automatically tell us what caused the original sleep difficulty or whether the product is the best explanation for a change over time.
Before you add it
Melatonin has pharmacologic effects and may interact with prescription medications, over-the-counter medications, and medical conditions.
The clearest interaction concerns include blood-thinning medications and seizure disorders. The National Center for Complementary and Integrative Health notes that people taking blood thinners and people with epilepsy should be under medical supervision when using melatonin. Melatonin metabolism can also be affected by factors including fluvoxamine, oral contraceptives, smoking, and caffeine, so a medication-and-supplement review matters more than a generic online interaction checker.
Pregnancy and breastfeeding are another uncertainty because safety research is lacking. In older adults, melatonin may remain active longer and contribute to daytime drowsiness. Product quality, accidental ingestion by children, allergy, and upcoming surgery are also relevant considerations.
A better question than “Should I take it?”
Melatonin is neither a trivial vitamin nor a universal sleep solution. It is a hormone-related supplement used in a marketplace where formulation, timing, content accuracy, and evidence quality all vary.
That does not require alarm. It requires precision.
The better question may be: What problem am I trying to solve, what outcome would count as meaningful, and what does this particular product and evidence base allow me to conclude?
Written for Dr. Teralyn Sell, PhD
Psychology · Brain Health · Human Behavior
Sources worth knowing
- Exogenous Melatonin and Sleep Quality: A Scoping Review of Systematic Reviews
- Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis
- A Survey of Melatonin in Dietary Supplement Products Sold in the United States
- Melatonin: What You Need To Know
- Clinical Pharmacokinetics of Melatonin: A Systematic Review